drugset / Trial / NCT02231788

The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy

NCT02231788

Phase 4 Completed 217 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

The Efficacy of a Fixed Dose Combination of Telmisartan/S-Amlodipine on 24-hour Ambulatory BP Control Compared with Telmisartan Monotherapy

Timeline

Start
2014-06
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject S-amlodipine Unknown 2.5 mg Oral
Comparator Telmisartan Other / unclassified 40 mg Oral
Comparator Telmisartan Other / unclassified 80 mg Oral

Indications